Poly Medicure
Poly Medicure, also known as Poly Medicure Limited, is a leading player in the medical device industry, headquartered in India. Established in 1998, the company has made significant strides in the healthcare sector, particularly in the fields of infusion therapy, vascular access, and wound care. With a strong operational presence across Asia, Europe, and the Americas, Poly Medicure has positioned itself as a trusted provider of innovative medical solutions. The company’s core offerings include a diverse range of products such as intravenous catheters, blood transfusion sets, and surgical sutures, all designed with a focus on safety and efficacy. Poly Medicure is recognised for its commitment to quality and has achieved several certifications, enhancing its reputation in the global market. With a robust portfolio and a dedication to advancing healthcare, Poly Medicure continues to set benchmarks in the medical device industry.
DitchCarbon Score
How does Poly Medicure's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Poly Medicure's score of 23 is lower than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Poly Medicure's reported carbon emissions
In 2024, Poly Medicure reported total carbon emissions of approximately 36,820,130 kg CO2e, comprising 2,319,850 kg CO2e from Scope 1 and 33,962,280 kg CO2e from Scope 2. This reflects a consistent emission profile compared to previous years, with similar figures reported in 2023 and 2022. Specifically, in 2023, the company recorded total emissions of about 36,942,130 kg CO2e, while in 2022, emissions were approximately 33,275,560 kg CO2e, indicating a slight increase in emissions over the years. Poly Medicure has not disclosed any Scope 3 emissions data, nor have they set specific reduction targets or climate pledges. The company’s emissions intensity per rupee of turnover has shown a gradual increase, with values of 2.7e-09 in 2024 and 3.1e-09 in 2023, suggesting a need for enhanced strategies to manage and reduce their carbon footprint effectively. Overall, while Poly Medicure has maintained transparency in reporting their emissions, the absence of defined reduction initiatives or climate commitments highlights an area for potential improvement in their sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 3,114,940 | 0,000,000 | 0,000,000 |
| Scope 2 | 30,230,620 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Poly Medicure is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
